+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Propranolol Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243981
UP TO OFF until Jan 01st 2027
The Propranolol Market is estimated at US$491.5 million in 2026 and is projected to grow at a CAGR of 4% to reach US$672.7 million by 2034.

Market Overview

The Propranolol Market covers propranolol pharmaceutical formulations supplied through branded and generic medicine channels.

Formulation and product presentation influence purchasing within the intended clinical use; access, distribution and dependable quality shape commercial supply.

Key Companies Analysed

  • AstraZeneca
  • Teva Pharmaceutical Industries
  • Viatris
  • Sun Pharma
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • Cipla
  • Sandoz
  • Apotex
  • Torrent Pharmaceuticals
  • Zydus Lifesciences
  • Amneal Pharmaceuticals
  • Lupin
  • Bausch Health
  • Pfizer
  • Sanofi
  • Merck KGaA
  • Hikma Pharmaceuticals
  • Accord Healthcare
  • Macleods Pharmaceuticals

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Propranolol Market Overview
2.1. Propranolol Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Propranolol Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Propranolol Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Propranolol Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
6. North America Propranolol Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Propranolol Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Propranolol Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Propranolol Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Propranolol Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Propranolol Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. AstraZeneca
11.2.2. Teva Pharmaceutical Industries
11.2.3. Viatris
11.2.4. Sun Pharma
11.2.5. Dr. Reddy's Laboratories
11.2.6. Aurobindo Pharma
11.2.7. Cipla
11.2.8. Sandoz
11.2.9. Apotex
11.2.10. Torrent Pharmaceuticals
11.2.11. Zydus Lifesciences
11.2.12. Amneal Pharmaceuticals
11.2.13. Lupin
11.2.14. Bausch Health
11.2.15. Pfizer
11.2.16. Sanofi
11.2.17. Merck KGaA
11.2.18. Hikma Pharmaceuticals
11.2.19. Accord Healthcare
11.2.20. Macleods Pharmaceuticals
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • AstraZeneca
  • Teva Pharmaceutical Industries
  • Viatris
  • Sun Pharma
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • Cipla
  • Sandoz
  • Apotex
  • Torrent Pharmaceuticals
  • Zydus Lifesciences
  • Amneal Pharmaceuticals
  • Lupin
  • Bausch Health
  • Pfizer
  • Sanofi
  • Merck KGaA
  • Hikma Pharmaceuticals
  • Accord Healthcare
  • Macleods Pharmaceuticals

Table Information